Aspiriant LLC’s Nuveen ESG Small-Cap ETF NUSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-6,506
Closed -$227K – 314
2023
Q3
$227K Hold
6,506
– – 0.01% 255
2023
Q2
$241K Hold
6,506
– – 0.01% 255
2023
Q1
$230K Hold
6,506
– – 0.01% 254
2022
Q4
$222K Hold
6,506
– – 0.01% 247
2022
Q3
$209K Hold
6,506
– – 0.01% 248
2022
Q2
$213K Hold
6,506
– – 0.01% 259
2022
Q1
$259K Hold
6,506
– – 0.01% 237
2021
Q4
$273K Hold
6,506
– – 0.01% 238
2021
Q3
$283K Hold
6,506
– – 0.02% 199
2021
Q2
$294K Hold
6,506
– – 0.02% 201
2021
Q1
$280K Buy
+6,506
New +$275K 0.02% 185

Other funds holding NUSC

Aspiriant LLC's NUSC Position: Q4 2023 in Review

Aspiriant LLC sold out of Nuveen ESG Small-Cap ETF (NUSC) in Q4 2023, closing a stake of 6,506 shares — an estimated $227K sold.

Aspiriant LLC first reported a position in NUSC in Q1 2021 and held it in 11 quarters. The position peaked at $294K in Q2 2021. 228 funds tracked by Wall St. Rank hold NUSC as of Q4 2023.

  • Aspiriant LLC reported no remaining Nuveen ESG Small-Cap ETF position as of Q4 2023 after selling out during the quarter.
  • Aspiriant LLC sold 6,506 Nuveen ESG Small-Cap ETF shares in Q4 2023, an estimated $227K.
  • Aspiriant LLC first reported a position in Nuveen ESG Small-Cap ETF in Q1 2021 and held it in 11 quarters.
  • Aspiriant LLC's Nuveen ESG Small-Cap ETF position peaked at $294K in Q2 2021.
  • 228 funds tracked by Wall St. Rank held Nuveen ESG Small-Cap ETF as of Q4 2023.

Based on Aspiriant LLC's 13F filing for Q4 2023, filed 26 Jan 2024.